Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial

Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial

Reynold A Panettieri Jr,1 Carlos A Camargo Jr,2 Tariq Cheema,3 Sherif G El Bayadi,4 Stanley Fiel,5 Tania M Vila,6 Renu G Jain,6 Dawn Midwinter,7 Byron Thomashow,8 Andrea Ludwig-Sengpiel,9 David A Lipson10,11 1Child Health Institute of New Jersey, Rutgers University School of Medicine, New Brunswick,...

Full description

Bibliographic Details
Main Authors: Panettieri Jr RA, Camargo CA Jr, Cheema T, El Bayadi SG, Fiel S, Vila TM, Jain RG, Midwinter D, Thomashow B, Ludwig-Sengpiel A, Lipson DA
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:International Journal of COPD
Subjects:
copd
exacerbations
severe exacerbations
triple therapy
ics/laba
Online Access:https://www.dovepress.com/effect-of-recent-exacerbation-history-on-the-efficacy-of-once-daily-si-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/effect-of-recent-exacerbation-history-on-the-efficacy-of-once-daily-si-peer-reviewed-fulltext-article-COPD

Similar Items